NCT00688493 - Effects of Single Oral Dose Dapagliflozin QT Study | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

July 31, 2007

Study Completion Date

April 30, 2008

Conditions

Healthy

Interventions

DRUG

Dapagliflozin

3 x 50 mg tablets, single oral dose

DRUG

Dapagliflozin

2 x 10 mg capsules, single oral dose

DRUG

Moxifloxacin

Overencapsulated 400 mg capsule, single oral dose

DRUG

Placebo to match moxifloxacin and dapagliflozin

Overencapsulated 400 mg capsule, single oral dose

Trial Locations (1)

Research Site, Baltimore